Friedhuber, Anna M
< Back to all Authors2008
Dass, Crispin R, Friedhuber, Anna M, Khachigian, Levon M, Dunstan, David E and Choong, Peter F. M (2008) Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity. Journal of Microencapsulation, 25 (6). pp. 421-425. ISSN 0265-2048
July 2008
Dass, Crispin R, Friedhuber, Anna M, Khachigian, Levon M, Dunstan, David E and Choong, Peter F. M (2008) Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model. Cancer Biology and Therapy, 7 (7). pp. 1033-1036. ISSN 1538-4047
2010
Tan, Mei Lin, Dunstan, David E, Friedhuber, Anna M, Choong, Peter F. M and Dass, Crispin R (2010) A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site. Journal of Controlled Release, 144 (2). pp. 196-202. ISSN 0168-3659
Tan, Mei Lin, Friedhuber, Anna M, Dunstan, David E, Choong, Peter F. M and Dass, Crispin R (2010) The performance of doxorubicin encapsulated in chitosan–dextran sulphate microparticles in an osteosarcoma model. Biomaterials, 31 (3). pp. 541-551. ISSN 0142-9612
January 2013
Tan, Mei Lin, Friedhuber, Anna M and Dass, Crispin R (2013) Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model. Journal of Pharmacy and Pharmacology, 65 (1). pp. 35-43. ISSN 0022-3573 (print) 2042-7158 (online)
January 2015
Friedhuber, Anna M, Chandolu, Vijay, Manchun, Somkamon, Donkor, Osaana ORCID: 0000-0001-9565-9024, Sriamornsak, Pornsak and Dass, Crispin R (2015) Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis. Journal of Pharmacy and Pharmacology, 67 (1). 68 - 77. ISSN 0022-3573